Rocket Pharmaceuticals (RCKT) Net Income (2016 - 2025)
Historic Net Income for Rocket Pharmaceuticals (RCKT) over the last 10 years, with Q3 2025 value amounting to -$52.0 million.
- Rocket Pharmaceuticals' Net Income rose 2414.68% to -$52.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$248.2 million, marking a year-over-year increase of 745.13%. This contributed to the annual value of -$266.8 million for FY2024, which is 412.81% down from last year.
- Rocket Pharmaceuticals' Net Income amounted to -$52.0 million in Q3 2025, which was up 2414.68% from -$71.1 million recorded in Q2 2025.
- In the past 5 years, Rocket Pharmaceuticals' Net Income ranged from a high of -$33.8 million in Q2 2021 and a low of -$71.9 million during Q2 2024
- In the last 5 years, Rocket Pharmaceuticals' Net Income had a median value of -$61.6 million in 2024 and averaged -$57.9 million.
- Examining YoY changes over the last 5 years, Rocket Pharmaceuticals' Net Income showed a top increase of 2753.09% in 2021 and a maximum decrease of 7122.35% in 2021.
- Rocket Pharmaceuticals' Net Income (Quarter) stood at -$43.9 million in 2021, then crashed by 55.43% to -$68.3 million in 2022, then increased by 7.86% to -$62.9 million in 2023, then increased by 2.2% to -$61.6 million in 2024, then rose by 15.5% to -$52.0 million in 2025.
- Its Net Income stands at -$52.0 million for Q3 2025, versus -$71.1 million for Q2 2025 and -$63.5 million for Q1 2025.